Litsa Lambrakos, MD
Clinical Cardiac Electrophysiology · Miami, FLNPI 1801039953
Payments from drug & device makers
Across 378 payments — averaging $269.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$84K
- Cordis US CORP.$7K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$5K
- Abbott$3K
- Boston Scientific$747
- Cardiva Medical, Inc.$339
- plus $1K from 8 others
What the payments were for
- Consulting fees$49,66349%
- Speaking & faculty fees$21,75021%
- Travel & lodging$18,61618%
- Food & beverage$11,69811%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 266 | $84,167 |
| Cordis US CORP. | 1 | $6,900 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $4,941 |
| Abbott | 49 | $3,439 |
| Boston Scientific | 18 | $747 |
| Cardiva Medical, Inc. | 13 | $339 |
| Biosense Webster, Inc. | 9 | $280 |
| Medical Device Business Services, Inc. | 7 | $230 |
| AstraZeneca | 2 | $227 |
| Heartflow, Inc. | 1 | $149 |
| Impulse Dynamics (USA) Inc. | 2 | $139 |
| Biotronik Inc. | 1 | $86 |
| Irhythm Technologies, Inc. | 1 | $53 |
| Cvrx, Inc. | 2 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYNX CONTROL$6,900
- LifeVest$4,839
- AVEIR$1,417
- ENSITE PRECISION$807
- AURORA EV-ICD MRI SURESCAN$502
- Arctic Front$481
- Micra$443
- COBALT DR MRI SURESCAN$301
- LINQ II$279
- Cobalt$156
- FFRct$149
- S-ICD System Magnet$131
- Resolute$131
- AZURE XT DR MRI SURESCAN$124
- EVERA MRI XT DR SURESCAN$123
- Trifecta GT Tissue Heart Valve$113
- Sentinel$112
How this compares
$101,727 in reported general payments places this provider in the 75th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 39 | $58,782 |
| Metoprolol Succinate | 94 | $969 |
| Amiodarone Hcl | 24 | $423 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 22 | $275 |
| Bisoprolol Fumarate | 16 | $271 |
| Flecainide Acetate | 15 | $242 |
| Atorvastatin Calcium | 21 | $106 |
| Furosemide | 13 | $77 |
| Atenolol | 12 | $26 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Miami
- Jose Osorio FilhoMiami$16.4M
- Mario PascualMiami$158K
- Ivan MendozaMiami$122K
- Saumil OzaJacksonville$4.1M
- Usman SiddiquiWinter Park$3.6M
- David KenigsbergFort Lauderdale$1.3M
- Venkata SagiJacksonville$1.2M
- Raul WeissMiami Beach$1.1M
- Robert FishelAtlantis$1.1M
- Naushad ShaikKissimmee$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.